The Canadian Pulmonary Fibrosis Foundation (CPFF) is a resource for all patients and families affected by pulmonary fibrosis. One of our primary goals is to connect the community and support individual and broader advocacy efforts. We aim to raise public and government awareness of the disease, and the issues facing the community.

The CPFF focuses its efforts on advocating with, and on behalf of, patients, caregivers, family members or friends, to improve access to much-needed care and treatment for pulmonary fibrosis. The introduction of new treatments, and obtaining access to these important tools, will help to improve the lives of those living with IPF.

With your support, we can make a difference for all Canadians affected by this life-limiting disease by helping to ensure patients have access to Esbriet (pirfenidone), the first and only proven medicine available to treat idiopathic pulmonary fibrosis (IPF). It has been shown to slow disease progression and to decrease the decline in lung function in adult patients with mild to moderate IPF.

As part of our advocacy efforts for access to Esbriet, we have added to this section of our website the tools and resources listed below, so that it is easy for you to get engaged.